Lead Generation Approaches in Drug Discovery (eBook)
308 Seiten
John Wiley & Sons (Verlag)
978-0-470-58416-3 (ISBN)
discovery
Lead generation is increasingly seen as a distinct and
success-determining phase of the drug discovery process. Over
recent years, there have been major advances in the understanding
of what constitutes a good lead compound and how to improve the
chances of finding such a compound. Written by leading scientists
and established opinion leaders from industry and academia, this
book provides an authoritative overview of the field, as well as
the theory, practice, and scope, of the principal Lead
Generation Approaches in Drug Discovery, including:
* The evolution of the lead discovery process, key concepts,
current challenges, and future directions
* Strategies and technologies driving the high-throughput
screening (HTS) approach to lead discovery, including the shifting
paradigms in the design of compound collections and best practice
in the hit confirmation process
* Knowledge-based in silico or "virtual" screening
* Theory and practice of the fragment-based approach to lead
discovery
* The opportunities and challenges presented by multi-target drug
discovery (MTDD)
* De novo design of lead compounds and new approaches to
estimating the synthetic accessibility of de novo-designed
molecules
* The impact of natural products on drug discovery, and potential
of natural product-like compounds for exploring regions of
biologically relevant chemical space
* Using early screening of hits and leads for metabolic,
pharmacokinetic, and toxicological liabilities to reduce attrition
during the later phases of drug discovery
* The utility of parallel synthesis and purification in lead
discovery
With each topic supported by numerous case studies, this is
indispensable reading for researchers in industry and academia who
wish to keep up to date with the latest strategies and approaches
in drug discovery.
ZORAN RANKOVIC is a Senior Research Fellow and Associate Director in Medicinal Chemistry at Schering-Plough Research Institute, UK. He received his PhD in organic chemistry from the University of Leeds (UK) before starting his medicinal chemistry career in 1995 at Organon, UK. Since then, working on projects over a range of therapeutic areas, including psychosis, analgesia, and cardiovascular and bone diseases, he gained extensive experience in all stages of the drug discovery process, including lead generation. From this work, Dr. Rankovic has authored or coauthored over fifty scientific publications, book chapters, and patents, and has given invited lectures at numerous international conferences. RICHARD MORPHY is a medicinal chemistry section head at Schering-Plough Research Institute (SPRI) at Newhouse, Scotland. He has twenty years' experience in the pharmaceutical industry, previously working for Celltech and Organon on a wide range of oncology, inflammation, psychiatry, and analgesia projects. In addition to his extensive experience of the lead discovery process, he has a keen interest in the development of medicinal chemistry in emerging economies and is an opinion leader in the area of multi-target drug discovery.
PREFACE.
CONTRIBUTORS.
1 Lead Discovery: The Process (William F. Michne).
2 High Throughput Screening Approach to Lead Discovery (Zoran
Rankovic, Craig Jamieson, and Richard Morphy).
3 In Silico Screening (Dagmar Stumpfe, Hanna Geppert, and
Jürgen Bajorath).
4 Fragment-Based Lead Discovery (Jeffrey S. Albert).
5 Design of Multitarget Ligands (Richard Morphy and Zoran
Rankovic).
6 De novo Drug Design (Gisbert Schneider, Markus
Hartenfeller, and Ewgenij Proschak).
7 Role of Natural Products in Drug Discovery (Hugo Lachance,
Stefan Wetzel, and Herbert Waldmann).
8 Early Screening for ADMET Properties (Dennis A.
Smith).
9 Role of Chemistry in Lead Discovery (Roland E. Dolle and
Karin Worm).
INDEX.
"The book provides a comprehensive overview of many aspects of the
lead generation process . . . The book delivers a good introduction
to the process of lead generation for novice researchers. It is
also useful for more experienced scientists to update their
knowledge and/or to identify some new details." (ChemMedChem,
October 2010)
"This volume is recommended to chemists and biologists who wish
to learn about the practice of high throughput screening and about
the concepts involved in making the method a successful route to
drug discovery." (Journal of Medicinal Chemistry, 2010)"Each
chapter provides a comprehensive overview of one aspect of the lead
generation process. To get more indepth knowledge, extensive
references including recent publications are given."
(ChemMedChem, 2010)
| Erscheint lt. Verlag | 5.5.2010 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie |
| Naturwissenschaften ► Chemie | |
| Schlagworte | Chemie • Chemistry • Computational Chemistry & Molecular Modeling • Computational Chemistry u. Molecular Modeling • Drug Discovery & Development • Medical Science • Medizin • Pharmacology & Pharmaceutical Medicine • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung |
| ISBN-10 | 0-470-58416-5 / 0470584165 |
| ISBN-13 | 978-0-470-58416-3 / 9780470584163 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich